Surface temperatures were measured from the forearm, palm, anterior leg, and calf for the median motor, median sensory, peroneal, and sural recordings, respectively, immediately before and after each recording, as done in the DCCT. Electromyographers were provided with the DCCT closeout temperatures and instructed to approximate the temperatures to the extent possible. The averaged pre-and post-recording temperatures from the forearm, palm, anterior leg, and calf during NeuroEDIC were 33.1º C, 33.0º C, 32.4º C, and 32.0º C, respectively. These temperatures did not differ significantly from the DCCT closeout temperatures, and there were no significant treatment group differences in surfaces temperatures at DCCT closeout or EDIC year 13-14.
percentile, and amplitude as 0. The Wilcoxon rank-sum test assessed group differences in ordinal or quantitative variables, and the contingency Chi-square test for categorical variables. NCS values were ranked from lowest to highest, lower values reflecting greater abnormality, for all attributes except F response latency where higher values (indicating greater abnormality) were assigned lower ranking. Midranks were used for tied ranks. Rank-transformation analysis of covariance (ANCOVA) assessed group differences in the ranks of the 10 NCS measures in EDIC at DCCT baseline or closeout, adjusted for the mean NCS rank at DCCT closeout and both the DCCT and EDIC limb temperature during the nerve conduction study. The overall treatment group difference in the 10 NCS measures was assessed using the nonparametric Wei-Lachin rank test of stochastic ordering (11) that assesses whether one group on average tends to have better outcomes for all 10 measures than the other group.
Logistic regression models assessed group differences in, and other covariate effects on, the odds of an outcome. Analyses of prevalent neuropathy at EDIC year 13-14 employed all subjects assessed, whereas analyses of incident outcomes excluded subjects with the specific neuropathy outcome at the preceding evaluation. Models also adjusted for the average rank of NCS results at DCCT closeout to control for residual differences between groups.(12) Separate models adjusted for the average rank of all NCS measures, all leg measures, leg amplitude and conduction velocity measures, and peroneal and sural amplitude and peroneal conduction velocity. Additional covariates evaluated included age, sex, height, weight, body mass index (BMI), cardiovascular risk factors, and medications (analgesics and ACE/ARBs). A forward 7.4 (1.0) † 7.9 (1.2) 9.2 (1.5) 7.3 (1.0) † 7.8 (1.2) CONV 8.9 (1.6) 9.2 (1.5) 7.8 (1.1) 9.0 (1.6) 9.0 (1.5) 7.7 (1.2) Systolic BP, mean (SD), mmHg INT 112 (11) † 115 (11) 121 (14) 114 (12) † 118 (12) 121 (14) CONV 114 (12) 115 (11) 119 (14) 116 (12) 118 (12) 122 (14) Diastolic BP, mean (SD), mmHg INT 72 (9) 74 (9) 75 (9) 73 (9) 75 (8) 73 (9) CONV 72 (9) 73 (9) 74 (9) 74 (9) 75 (9) 73 (9) Total cholesterol, mean (SD), mg/dl INT 177 (33) 179 (30) 181 (37) 178 (34) 182 (32) 171 (35) CONV 169 (33) 180 (35) 172 (35) 178 (32) 186 (37) 174 ( 
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